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Abstract
Tibial dyschondroplasia (TD) appears to involve a failure of the growth plate chondrocytes within growing long bones to
differentiate fully to the hypertrophic stage, resulting in a mass of prehypertrophic chondrocytes which form the avascular
TD lesion. Many biochemical and molecular markers of chondrocyte hypertrophy are absent from the lesion, or show
reduced expression, but the cause of the disorder remains to be identified. As differentiation to the hypertrophic state is
impaired in TD, we hypothesised that chondrocyte genes that are differentially expressed in the growth plate should show
altered expression in TD. Using differential display, four genes, B-cadherin, EF2, HT7 and Ex-FABP were cloned from
chondrocytes stimulated to differentiate to the hypertrophic stage in vitro, and their differential expression confirmed in vivo.
Using semi-quantitative RT-PCR, the expression patterns of these genes were compared in chondrocytes from normal and
TD growth plates. Surprisingly, none of these genes showed the pattern of expression that might be expected in TD lesion
chondrocytes, and two of them, B-cadherin and Ex-FABP, were upregulated in the lesion. This indicates that the TD
phenotype does not merely reflect the absence of hypertrophic marker genes, but may be influenced by more complex
developmental mechanisms/defects than previously thought. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Chondrocyte terminal di¡erentiation in the growth
plate is of pivotal importance in the process of en-
dochondral ossi¢cation [1]. Chondrocytes from the
resting zone of the growth plate proceed through a
series of intermediate phenotypes: proliferating, pre-
hypertrophic and hypertrophic, before reaching a ter-
minally di¡erentiated state [2,3]. Tibial dyschondro-
plasia (TD) is a common cause of bone deformity in
broiler chickens which is characterised by an opaque
avascular lesion in the metaphysis of long bones [4].
It occurs most frequently in the proximal tibiotarsus,
although other joints may also be a¡ected [5]. The
lesion appears to contain predominantly prehyper-
trophic chondrocytes, with fully hypertrophic cells
absent [6]. In addition, genes that are normally upre-
gulated during chondrocyte hypertrophy tend to
show a lower level of expression in the TD lesion.
This has been shown to be the case for a number of
genes, including matrix components [7^9], growth
factors [10^12] and receptors [13]. These data sup-
port the conclusion that TD involves a failure of
0925-4439 / 00 / $ ^ see front matter ß 2000 Elsevier Science B.V. All rights reserved.
PII: S 0 9 2 5 - 4 4 3 9 ( 0 0 ) 0 0 0 2 0 - X
* Corresponding author. Fax: +44-131-440-0434;
E-mail : david.je¡eries@bbsrc.ac.uk
BBADIS 61936 19-5-00
Biochimica et Biophysica Acta 1501 (2000) 180^188
www.elsevier.com/locate/bba
growth plate chondrocytes to reach the terminally
di¡erentiated hypertrophic state [6,14].
In order to test the hypothesis that TD is caused
by the arrest of chondrocyte di¡erentiation, we have
used an in vitro model of chondrocyte di¡erentiation
[15,16], to isolate di¡erentially expressed genes, and
then compared the mRNA level of these genes in
normal and TD lesion chondrocytes. If the above
hypothesis is correct, then genes normally upregu-
lated in hypertrophic chondrocytes should show re-
duced expression in the TD lesion. Here, we report
the expression patterns of four di¡erentially regu-
lated genes cloned from chondrocytes by agarose
gel di¡erential display [17]. Surprisingly, two of these
genes, ExFABP and B-cadherin, were upregulated in
lesion chondrocytes, and were expressed at levels that
were not compatible with the absence of hypertro-
phic chondrocytes from the TD lesion. Nor could
this upregulation be explained by changes known
to occur in lesion chondrocytes. This suggests that
the TD phenotype may not merely re£ect the absence
of fully hypertrophic cells from the lesion [14,18], but
may be due to more complex mechanisms than pre-
viously thought.
2. Materials and methods
2.1. Di¡erential display
The identi¢cation of di¡erentially expressed genes
was performed by the technique of agarose gel di¡er-
ential display [19], modi¢ed to allow the use of total
RNA [17]. Brie£y, proliferating chondrocytes iso-
lated from the growth plate of the proximal tibiotarsi
of 3-week-old chickens were grown in culture for 6^7
days in the presence or absence of ascorbic acid, a
substance known to induce di¡erentiation to the hy-
pertrophic state [15], and the cells harvested for the
extraction of total RNA as described below. RNA
was reverse transcribed using random hexamers and
di¡erential display was performed using a number of
di¡erent combinations of two arbitrary 10-mer prim-
ers [19]. Bands that were reproducibly di¡erentially
expressed were excised from the gel and cloned into a
TA vector (PCR-II; InVitrogen, the Netherlands).
Di¡erential expression was assessed by a non-radio-
active dot blotting technique and semi-quantitative
RT-PCR, or by Northern blotting [17,20]. Four
genes that were con¢rmed as di¡erentially expressed
in the chick growth plate, as well as in ascorbic acid-
treated cells, were then assayed for altered expression
in TD lesion chondrocytes (see below).
2.2. Chondrocyte isolation
Isolation and culture of growth plate chondrocytes
for di¡erential display was carried out as previously
described [17]. To con¢rm the in vivo di¡erential
expression of genes isolated from chondrocytes
grown in culture, separate sections were dissected
from the top and bottom of normal growth plates,
so as to represent cell populations of predominantly
proliferating (P) and hypertrophic (H) chondrocytes.
Material from these samples was diced into small
cubes and chondrocytes isolated from their sur-
rounding matrix by digestion with 0.3% collagenase
A (Roche Diagnostics, UK) and 0.1% hyaluronidase
(Sigma, UK) in Dulbecco’s modi¢ed Eagle’s medium
(BRL Life Technologies, UK) for 4 h at 37‡C. Un-
digested matter was removed with a 45-Wm ¢lter the
cells washed with DMEM and pelleted for extraction
of total RNA. Growth plate chondrocytes from TD
and non-TD birds were obtained from broiler chicks
(Ross strain) raised on a calcium/phosphorus imbal-
anced, TD-inducing diet, containing 7.5 g/kg calci-
um, 7.6 g/kg phosphorus and 25 mg/kg vitamin D3,
which resulted in an increased incidence of the dis-
order [7]. Chicks were sacri¢ced at 3 weeks of age,
the proximal tibiotarsi split longitudinally and scored
visually for TD according to a standard scale of se-
verity [14]. Chondrocytes were isolated from the en-
tire growth plate of TD and non-TD birds, with TD
lesion material divided into small (S; TD score of
1 or 2) and large (L; TD score of 3 or greater)
samples. Care was taken to include comparable areas
of the growth plate for both TD and non-TD sam-
ples. Chondrocytes were isolated by collagenase di-
gestion as described above and total RNA extracted
directly from the pelleted cells.
2.3. RNA extraction
Total RNA was extracted from isolated chondro-
cytes using Ultraspec II according to the manufac-
turer’s instructions (Biotecx, USA). Brie£y, cells were
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resuspended in 1 ml of Ultraspec II and the suspen-
sion passed repeatedly through an 18-gauge needle.
After incubation on ice, the RNA was extracted with
chloroform and the aqueous phase recovered. The
RNA was then bound to RNATack resin (Biotecx)
in the presence of isopropanol and recovered by brief
centrifugation. After washing with 75% ethanol, the
RNA was eluted in a small volume of 10 mM Tris
(pH 8.0).
2.4. RT-PCR
Total RNA was reverse transcribed with random
hexamers in aliquots of 1 Wg using the Superscript
preampli¢cation system (BRL Life Technologies).
PCR reactions were carried out in a volume of 10
Wl in 200 Wl thin-walled tubes using a Robocycler
PCR machine (Stratagene, UK). The reactions con-
tained TLA bu¡er [21,17], 0.05% W-1 detergent
(BRL Life Technologies), 1 U of Taq polymerase
(Advanced Biotechnologies, UK), in the presence of
Taqstart antibody (Clontech, UK) and the equiva-
lent of 10 ng of target RNA. The ¢nal concentration
of the primers was 1 WM. The temperature pro¢le of
the PCR reactions was 95‡C for 30 s, 58‡C for 60 s
and 72‡C for 60 s. The number of PCR cycles was
carefully titrated to ensure that the reactions were in
the exponential phase. The number of cycles used
were: B-cadherin 30 cycles, HT7 28 cycles, EF2 27
cycles, Ex-FABP 26 cycles and GAPDH 22 cycles.
Ex-FABP was previously referred to as Ch21 [22].
Reaction products were run out on 3% NuSieve
agarose gels (Flowgen, UK), stained with ethidium
bromide and a record of the gel made using the Bio-
Rad gel documentation system (Bio-Rad, UK). For
comparison of TD and non-TD samples, band inten-
sity was quanti¢ed using Molecular Analyst gel doc-
umentation software (Bio-Rad). Relative levels of ex-
pression were estimated in arbitrary units, with the
control band assigned a value of 1. Each gene was
assayed at least three times and the results collated
and analysed statistically using a one sample t-test
within the Statview statistics package (Abacus con-
cepts, USA).
2.5. Gene speci¢c primers
Ex-FABP: forward, 5P-GAC TTC TTC CTG
CGT GAG AAG G-3P ; reverse, 5P-ATC AAC
GCT GCA TTC CTC CTG G-3P. HT7: forward,
5P-CTG TGG GGA TGA CCT GAT CTC-3P ; re-
verse, 5P-CTC TGA GCA TTA CCT GCT CTC-3P.
B-cadherin: forward, 5P-GTG ATC CCT CCC ATT
AAA GTT C-3P ; reverse, 5P-CTC CTT CTC AAT
GGT GAA GAT G-3P. EF-2: forward, 5P-TGA
AGT TCA GCG TCA GCC CTG T-3P ; reverse,
5P-TAG GAA TGC AAG CGT GGT CCT C.
GAPDH: forward, 5P-TGT GAC TTC AAT GGT
GAC AG-3P ; reverse, 5P-ACA GAT CAG TTT CTA
TCA GC-3P. The speci¢city of the primers was con-
¢rmed by cloning and sequencing of the PCR prod-
ucts (data not shown).
3. Results and discussion
3.1. Isolation of di¡erentially expressed genes
In an initial attempt to isolate candidate genes for
TD, we performed di¡erential display [17] using total
RNA isolated from TD lesion and normal growth
plates. However, this approach was hampered by
the lack of reproducibility of the banding patterns
obtained with both RNA samples, and the number
of false positives generated (D.J., unpublished). This
was most likely due to the heterogeneity of the chon-
drocyte populations isolated. Due to the nature of
the technique, di¡erential display is highly sensitive
to small variations in RNA abundance between sam-
ples, which renders comparison di⁄cult [23]. To
overcome this problem, we employed an alternative
strategy that exploits the impaired di¡erentiation of
lesion cells. We used an in vitro model of chondro-
cyte di¡erentiation [15,16] to isolate di¡erentially ex-
pressed genes, and then compared the mRNA level
of these genes in normal and TD lesion chondro-
cytes. If the hypothesis that TD is caused by the
arrest of chondrocyte di¡erentiation is correct, then
genes normally upregulated in hypertrophic chondro-
cytes should show reduced expression in the TD le-
sion. Here, we report the expression patterns of four
di¡erentially regulated genes cloned from chondro-
cytes by agarose gel di¡erential display [17] and
show that their pattern of expression does not ¢t
the above hypothesis.
In addition to the two gene fragments described
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previously (EF2 and Ex-FABP [17]), a further two
fragments were cloned by di¡erential display and
their di¡erential expression in ascorbic acid treated
chondrocytes con¢rmed (data not shown). These
fragments were sequenced and shown to have homol-
ogy to B-cadherin, a calcium-dependent cell adhesion
molecule [24] and the cell surface antigen HT7, which
is also involved in cell^cell interactions [25].
3.2. Con¢rmation of di¡erential expression
As well as verifying the di¡erential expression of
these four genes in culture, their regulation in growth
plate chondrocytes was also con¢rmed by comparing
populations of predominantly hypertrophic and pro-
liferating chondrocytes isolated from normal growth
plates (Fig. 1). The results show that while HT7 and
EF2 show moderate upregulation in proliferating
chondrocytes, both Ex-FABP and B-cadherin are
more highly expressed in hypertrophic cells.
The ¢nding that expression of B-cadherin is upreg-
ulated in hypertrophic chondrocytes was somewhat
surprising as there appears to be little cell^cell con-
tact between chondrocytes of the hypertrophic zone,
due to increased matrix production [26]. However,
interactions between cadherins and matrix compo-
nents such as integrins and collagens have been dem-
onstrated [27^29]. Integrins have been shown to be
important in regulating the progression of chondro-
cyte di¡erentiation within the growth plate [16,30].
Therefore, a role for B-cadherin in cell^matrix inter-
actions in the growth plate cannot be ruled out [31].
In addition, cadherins may be involved in apoptosis
[31], which has been shown to occur with increased
frequency in the hypertrophic zone [32,33].
HT7 is downregulated in hypertrophic chondro-
cytes from normal growth plates (Fig. 1). This may
well be due to a reduction in cell contact in the
hypertrophic zone of the growth plate, as HT7, like
B-cadherin, is a cell surface glycoprotein involved in
cell^cell interactions [25]. However, recent studies
have shown that EMMPRINN, the human homo-
logue of chick HT7, is closely associated with integ-
rins on the cell surface, and that both these moleculesFig. 1. Con¢rmation of di¡erential gene expression in total
RNA samples from populations of proliferating (P) and hyper-
trophic (H) growth plate chondrocytes. M = 100 base pair
marker.
Fig. 2. Expression of genes in total RNA samples from control
and TD lesion chondrocytes. PCR products from normal con-
trol (C), small (TDS) and large (TDL) lesion samples, run out
on agarose gels and stained with ethidium bromide. The level
of gene product in lesion cells was expressed in relation to the
band intensity in control cells run out in adjacent lanes on the
same gel (arbitrary value of band intensity in control lane = 1).
BBADIS 61936 19-5-00
D. Je¡eries et al. / Biochimica et Biophysica Acta 1501 (2000) 180^188 183
may function to regulate matrix metalloproteinase
activity [40]. The reduced expression of EF2, which
is an elongation factor catalysing the ribosomal syn-
thesis of polypeptides [41], is most likely a result of a
lower level of metabolic activity in terminally di¡er-
entiated hypertrophic cells [3].
The isolation of Ex-FABP from ascorbic acid
treated cells was reassuring as this gene is a recog-
nised marker of chondrocyte hypertrophy [46]. Ex-
FABP, or extracellular-fatty acid binding protein, is
a member of the lipocalin superfamily of proteins
that bind and transport small hydrophobic molecules
[47]. It is secreted into the extracellular matrix where
it probably binds to long-chain unsaturated fatty
acids, for which it has a high a⁄nity [22].
3.3. Expression patterns in TD lesion chondrocytes
The expression patterns of these four genes were
subsequently analysed in growth plate chondrocytes
isolated from TD and non-TD birds using semi-
quantitative RT-PCR. The GAPDH gene was used
as a control to ensure that equal amounts of cDNA
were compared between samples. Fig. 2 shows a typ-
ical result for each of the genes assayed in samples
from small and large TD lesions, together with a bar
chart showing the relative level of expression in the
TD and non-TD samples. The expression of EF2 and
HT7 did not di¡er signi¢cantly between normal and
lesion chondrocytes (Fig. 2 and Table 1). However,
both B-cadherin (Fig. 2a) and Ex-FABP (Fig. 2c)
were upregulated in chondrocytes from both small
and large lesions. In addition, the trend in both cases
was for increased di¡erences in the larger lesions
(Fig. 2).
The reason for the apparent upregulation of B-
cadherin in lesion material is not clear. There is little
evidence for increased cell^cell contact within the
lesion and increased expression may simply be due
to the particular phenotype of lesion chondrocytes.
Whether B-cadherin is involved in apoptosis in the
TD lesion is debatable. There are con£icting reports
on the frequency of programmed cell death in lesion
chondrocytes and both increased [34,35] and de-
creased [33] levels have been reported. One further
possibility is that a low level of calcium in the lesion
[36] is responsible for upregulation of B-cadherin.
Although there are con£icting reports on the levels
of calcium in dyschondroplasia [36,37], such a sce-
nario agrees with published observations of the
Table 1
Statistical analysis of TD expression data for the four genes cloned by di¡erential display
Gene Samplea nb Mean S.E.c Pd Signi¢cancee
BCAD S 7 0.167 0.053 0.02 P6 0.05
L 5 0.488 0.119 0.01 P6 0.01
S+L 12 0.301 0.073 0.002 P6 0.01
HT7 S 7 0.010 0.032 0.76 n.s.
L 4 0.002 0.031 0.95 n.s.
S+L 11 0.007 0.022 0.75 n.s.
Ex-FABP S 6 0.252 0.040 0.003 P6 0.01
L 4 0.315 0.054 0.01 P6 0.01
S+L 10 0.277 0.032 6 0.0001 P6 0.001
EF2 S 6 0.008 0.042 0.86 n.s.
L 4 0.039 0.023 0.19 n.s.
S+L 10 0.110 0.027 0.69 n.s.
GAPDH S 6 0.016 0.035 0.68 n.s.
L 3 30.034 0.055 0.60 n.s.
S+L 9 30.001 0.027 0.98 n.s.
The GAPDH gene was used as an internal control.
aS, small lesions; L, large lesions; S+L, small and large lesions combined.
bn = number of samples.
cS.E., standard error.
dP = probability value.
eLevel of signi¢cance, n.s., not signi¢cant.
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abundance and localisation of cadherins in osteo-
blasts cultured in low calcium medium [38]. Instead
of remaining at the cell surface, cadherin staining
was shifted to the cytoplasm and became much
more intense in cells exposed to low calcium. This
coincided with the appearance of a low molecular
weight band in Western blots probed with a cadherin
antibody. These observations are strikingly similar to
our own recent results with protein lysates from TD
lesions. Using a pan-cadherin antibody that recog-
nises a wide variety of cadherins [39], at least two
speci¢c bands are visible on Western blots of both
normal and TD growth plate chondrocyte lysates.
However, one band of about 30 kDa, while barely
detectable in normal growth plates, becomes ex-
tremely abundant in TD (DJ, unpublished observa-
tions). This is further evidence, albeit circumstantial,
that the avascular microenvironment of the TD le-
sion can in£uence gene expression levels.
In lesion material, mRNA levels of HT7 and EF2
are the same as those in the normal growth plate,
despite the absence of fully hypertrophic chondro-
cytes. This implies a reduction in the expression of
both genes in the cells of the lesion, compared to
prehypertrophic chondrocytes from normal growth
plates. In the case of HT7, this may indicate a reduc-
tion in cell^cell contact in the lesion, or be related to
a possible role in matrix metalloproteinase produc-
tion, as described above. Interestingly, matrix metal-
loproteinase activity produced by lesion chondro-
cytes in vitro, has been shown to be reduced
compared to normal growth plates [42]. For EF2,
expression levels probably re£ect a lower level of
metabolic activity and/or protein turnover in lesion
cells [43], as the cells are not proliferating or di¡er-
entiating. Certainly, those enzyme activities which
have been measured, such as alkaline phosphatase,
lactate dehydrogenase carbonic anhydrase, esterase,
triose phosphate isomerase and malate dehydrogen-
ase, are lower in, or absent from, the lesion
[14,44,45].
The reason for the increased expression of Ex-
FABP in lesion cells is intriguing as upregulation
of Ex-FABP is normally a marker of chondrocyte
hypertrophy [46]. Interestingly, it is also homologous
with p20k a protein often associated with quiescent
cells [48]. It has been shown that proliferating cells
are absent from the TD lesion [14]. Therefore, it is
possible that cell quiescence could account for the
upregulation of Ex-FABP, or even that elevated lev-
els of Ex-FABP prevent further cell division and ter-
minal di¡erentiation in the TD growth plate. Alter-
natively, the increased level of Ex-FABP mRNA may
be due to the particular phenotype of TD lesion cells.
In this context it is interesting to note that the upreg-
ulation of Ex-FABP has recently been con¢rmed at
the protein level in chondrocytes and myoblasts
treated with in£ammatory agents in culture, as well
as in chondrocytes from TD lesions and osteoar-
thritic cartilage [49]. It was suggested that increased
expression of the protein in the TD lesion may be
part of an acute phase response by lesion chondro-
cytes, although this has not yet been con¢rmed and
further work will be necessary to provide support for
this hypothesis.
The expression of HT7 and EF2, may be explained
by the particular characteristics of lesion chondro-
cytes. However, the remaining two genes examined
in this study, Ex-FABP and B-cadherin are, surpris-
ingly, upregulated in TD. This contradicts the hy-
pothesis that the lesion consists of mainly prehyper-
trophic chondrocytes [6,14], that do not express the
genes associated with hypertrophy [18]. Many of the
alterations in gene expression associated with the TD
lesion that have been reported concern proteins as-
sociated with the extracellular matrix of growth plate
chondrocytes. There are numerous examples of ma-
trix molecules and growth factors associated with
hypertrophy that show reduced levels of expression
in the lesion. These include: proteoglycans [8,50],
osteonectin [9], type X collagen [7,8,51], osteopontin
and bone sialoprotein [18], basic ¢broblast growth
factor [12] and transforming growth factor L-3
[10,11,50]. However, it is evident from the results
presented here, particularly for Ex-FABP and B-cad-
herin, that the phenotype of TD lesion chondrocytes
does not merely re£ect the absence of fully hyper-
trophic cells. Thus, although many of the changes
in gene expression in dyschondroplasia documented
to date are linked to the process of hypertrophy,
there may be other developmental defects that in£u-
ence the aetiology of TD. One possibility is that im-
paired vascularisation of the TD growth plate may
be involved in lesion formation. It has been demon-
strated that the lack of calci¢cation in the TD lesion
is due to impaired formation of functional matrix
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vesicles [36], and it was suggested that this is due to
reduced availability of mineral ions caused by an
inadequate blood supply. This failure of vascularisa-
tion may be due to a defect in the metaphyseal ves-
sels [52,53], or due to an absence of the angiogenic
signals necessary for capillary invasion to occur
[54,55]. In this context, it is interesting to note that
the production of angiogenic factors in the growth
plate is localised predominantly to the hypertrophic
zone [56^59], which contains precisely those cells that
appear to be absent from the lesion. Whatever the
cause, the absence of systemic factors, minerals and
nutrients from the TD growth plate is likely to per-
turb the normal expression pattern of a number of
genes, including B-cadherin and Ex-FABP.
4. Conclusions
The results presented here suggest that the forma-
tion of the dyschondroplastic lesion is not merely due
to the impaired terminal di¡erentiation of lesion
chondrocytes and that other developmental defects
occur that result in the TD phenotype. Further stud-
ies will be necessary to provide insight into the pre-
cise nature of the condition.
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